Therapeutic drug monitoring (TDM) is not yet accepted by systemic lupus erythematosus (SLE) treatment guidelines. Studies in SLE, however, have proven benefit in three areas: identification of non-adherence or poor adherence; targets for clinical benefit; and ranges of toxicity. This review covers the data on three medications commonly used for SLE, drawing on studies from both the SLE and non-SLE literature.

中文翻译：

---

系统性红斑狼疮的药物监测

治疗药物监测 (TDM) 尚未被系统性红斑狼疮 (SLE) 治疗指南所接受。然而，系统性红斑狼疮的研究已证明在三个方面有益： 识别不依从或依从性差；临床获益目标；和毒性范围。本综述涵盖了 SLE 常用的三种药物的数据，借鉴了 SLE 和非 SLE 文献中的研究。